Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report

被引：6
|
作者：
Montagna, E. [1 ]
Cancello, G. [1 ]
Torrisi, R. [1 ]
Rizzo, S. [2 ]
Scarano, E. [1 ]
Colleoni, M. [1 ]
机构：
[1] European Inst Oncol, Res Unit Med Senol, Dept Med, Milan, Italy
[2] European Inst Oncol, Div Diagnost Radiol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷 / 03期
关键词：
BEVACIZUMAB;
D O I：
10.1093/annonc/mdp563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：667 / U238
页数：2
相关论文
共 50 条
  • [11] Prolonged survival in a patient with metastatic HER2-positive inflammatory breast cancer: A case report
    Xia, Yu
    Luo, Jing
    ASIAN JOURNAL OF SURGERY, 2024, 47 (11) : 4934 - 4936
  • [12] Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine
    Mailliez, Audrey
    Servent, Veronique
    Bonneterre, Jacques
    Le Rhun, Emilie
    CASE REPORTS IN ONCOLOGY, 2014, 7 (02): : 555 - 559
  • [13] Lapatinib plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
    Watanabe, J.
    Hamauchi, S.
    Higashi, Y.
    Onozawa, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [14] Lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer: A systematic review
    Madden, Rebecca
    Kosari, Sam
    Peterson, Gregory M.
    Bagheri, Nasser
    Thomas, Jackson
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (02) : 72 - 80
  • [15] Lapatinib and trastuzumab combination shrinks HER2-positive cancer
    Coles, Charlotte
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (04) : 206 - 206
  • [16] Lapatinib moves forward in inflammatory and early HER2-positive breast cancer trials
    Tuma, Rabiya S.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (05) : 348 - 349
  • [17] Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report
    Jiao, Xiao-Dong
    Ding, Chunming
    Zang, Yuan-Sheng
    Yu, Guanzhen
    BMC CANCER, 2018, 18
  • [18] Combined lapatinib and paclitaxel in HER2-positive breast cancer
    Castaneda, Carlos A.
    Gomez, Henry L.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (06) : 308 - 309
  • [19] The emerging role of Lapatinib in HER2-positive breast cancer
    Alice Ulhoa-Cintra
    Larisa Greenberg
    Charles E. Geyer
    Current Oncology Reports, 2008, 10 : 10 - 17
  • [20] miRNAs in resistance to lapatinib in HER2-positive breast cancer
    Haley, V.
    Cavicchioli, F.
    Shia, A.
    O'Leary, K.
    Balakrishnan, L.
    Lo Nigro, C.
    Schmid, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S121 - S121
12345